Survey on Epidemiology of Hypoparathyroidism in France

Recruiting Observational Study
Hypoparathyroidism
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
European Georges Pompidou Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patient fro whom chronic hypoparathyroidism is diagnosed * patient living in France Exclusion Criteria: * patient who does not want his data to be collected in this registry * pseudo-hypoparathyroidism * acute hypoparathyroidism
Contacts

Jean-Philippe Bertocchio, MD, PhD

800-555-5555

jpbertocchio@gmail.com

CONTACT

Pascal Houillier, MD, PhD

800-555-5555

pascal.houillier@aphp.fr

CONTACT